Archive for October 2025

9-22-2025: CDC published new Clinical Recommendations for twice-a-year injectable lenacapavir as an additional option for HIV prevention in the United States. The U.S. Food and Drug Administration approved injectable lenacapavir, a prescribed medication, for HIV pre-exposure prophylaxis (PrEP) in June 2025. This is a significant step forward in expanding prevention options and reflects decades of research, partnership,…

9-25-25: The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV. For a comprehensive list of recent updates, please see What’s New in the Guidelines. The updates to the guidelines are outlined below.  New Chapter Added to the Guidelines (Five Sections) These guidelines are…

9-30-2025: The Panel on Antiretroviral Therapy and Medical Management of Children Living With HIV has reviewed and updated sections in the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. When to Initiate Antiretroviral Treatment in Children With HIV Infection Management of Children Receiving Antiretroviral Therapy Special Considerations for Antiretroviral Therapy Use in Adolescents…